DR.REDDY'S - BECOMING LEADER

Dr. K. Anji Reddy
Chairman

Established in 1984, Dr. Reddy’s Laboratories (NYSE: RDY) is an emerging global pharmaceutical company.

As a fully integrated pharmaceutical company, our purpose is to provide affordable and innovative medicines through our three core businesses:

• Pharmaceutical Services and Active Ingredients, comprising our Active Pharmaceuticals and Custom Pharmaceuticals businesses;
• Global Generics, which includes branded and unbranded generics; and
• Proprietary Products, which includes New Chemical Entities (NCEs), Differentiated Formulations, and Generic Biopharmaceuticals.

Our products are marketed globally, with a focus on India, US, Europe and Russia. Dr. Reddy’s conducts NCE research in the areas of metabolic disorders, cardiovascular indications, anti-infectives and inflammation.

Our strong portfolio of businesses, geographies and products gives us an edge in an increasingly competitive global market and allows us to provide affordable medication to people across the world, regardless of geographic and socio-economic barriers.

profile

Dr. Reddy’s began as an API manufacturer in 1984, producing high-quality APIs to first the Indian, and later, the international markets. In 1987, we started our formulations operations and, after becoming a force to reckon with in the Indian formulations market, went international in 1991.

In India, we have a product portfolio of over 200 brands in major therapeutic areas, with an emphasis on gastro-intestinal, cardiovascular, pain management, oncology, anti-infectives, probiotic, pediatrics and dermatology.

Today, our value proposition to our customers derives from an optimal operating system in which operations, product development and marketing & sales are fully integrated. Operations and the supply chain are aligned to ensure high availability, pull based replenishment of products at the retail level and superior inventory turns to our customers. This advantage is combined with a highly effective prescription generation detailing effort.

A field force of over 1,400 motivated and knowledgeable representatives supported by an integrated network of back-end services and armed with handheld devices for quick information access add value to every customer call and interaction.

With a range of over 200 brands across 13 therapeutic areas, Dr. Reddy’s aims to further consolidate its position as an industry leader in the Indian pharma market.

for more information log on to
http://www.drreddys.com